Hologic Corp (HOLX): Average Forecast Price

Corporate company logo of Hologic Inc (HOLX)

The Hologic, Inc. (HOLX) price chart illustrates the dynamics of a company whose financial stability is based on the implementation of diagnostic systems and FDA approvals. A niche focus on women's health is offset by global superiority in molecular research, where the indicator stands at 76.07. The business relies on the mass adoption of mammography systems, which ensures a steady cash flow from the sale of ancillary disposable components.

Hologic Inc - HOLX Consensus Target (period 07/04/2022 - 04/18/2026)

Analytical breakdowns for Hologic Corp (HOLX)

- share price and consensus valuation forecast:
Price Performance Chart hologic.com|HOLX - Price Target Chart
- stock exchange capitalization data:
Market Value Hologic Corp|HOLX - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Hologic|HOLX - Company Net Assets|Capitalization to Book Value Ratio hologic.com|HOLX - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Hologic, Inc.|HOLX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Hologic Medical|HOLX - Company Debts|Debts to Net Assets Hologic Corp|HOLX - Company Long-Term Debts|Company Current Liabilities Hologic|Immediate Liquidity hologic.com
- financial results and valuation multiples details:
HOLX - Company Net Income|Expected Profit Hologic, Inc.|HOLX - Price to Earnings Ratio|Future Price to Earnings Hologic Inc|HOLX - PEG Multiple|EV/EBITDA Multiple Hologic Corp|HOLX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Hologic|HOLX - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months hologic.com|HOLX - Earnings per share growth in current year|Expected net earnings per share growth next year Hologic, Inc.
Fundamental company analysis:HOLX, hologic.com
Original product of Hologic, Inc.

This indicator aggregates expert expectations regarding the asset's fair value, reflecting the balance between market demand and the fundamental effectiveness of management's strategy. By analyzing the vector of analyst consensus estimates, an investor can assess the margin of safety for Hologic, Inc. (HOLX) in the face of geopolitical fragmentation, which complicates equipment certification and disrupts supply chains for critical components of innovative medtech.

Competing companies

SYK (stryker.com) - Fair Value Consensus|Price Target Chart Medtronic MDT|Royal Philips (PHG) - Average Forecast Price|SNN - Price Target Chart|CSL: Price Target Chart|ITGR (Integer Holdings) - Consensus Target|Broker Consensus Forecast LIVN|Price Target Chart AdaptHealth|Consensus Target SS Innovations (SSII)|Analyst Consensus Forecast AVNS|Analyst Median Target shoulderinnovations.com|Price Target Chart Viemed Healthcare, Inc. VMD|Analyst Median Target Inogen Inc (INGN)|Owlet Care - Analyst Consensus Forecast|Quipt Home Medical Corp (QIPT) - Consensus Target|POCI: Analyst Consensus Forecast|Average Forecast Price PAVmed (PAVM)|Price Target Chart Tivic Health Systems|Price Target Chart MOVE|Price Target Chart Nuvo Group (NUVO)